Docetaxel anhydrous
CAS: 114977-28-5
EP/USP
USDMF No. 22562,USFDA Approved, EU GMP
CEP: R0-CEP 2013-174 Rev 00
EP/USP
USDMF No. 22562,USFDA Approved, EU GMP
CEP: R0-CEP 2013-174 Rev 00
Technical Data
| M. Wt | 807.9 |
| Formula | C43H53NO14 |
| CAS Number | 114977-28-5 |
| PubChem ID | 148124 |
| InChI Key | ZDZOTLJHXYCWBA-VCVYQWHSSA-N |
| Smiles | [H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1 |
| Documents | EU GMP, CEP, USFDA Approved, USDMF, India Registered with Form41 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Description
Docetaxel is a clinically well established anti-mitotic chemotherapy medication used mainly for the treatment of breast, ovarian, and non-small cell lung cancer. Docetaxel reversibly binds to tubulin with high affinity in a 1:1 stoichiometric ratio
Synonyms
Docetaxel, Docetaxel anhydrous, N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel, N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol, Taxotere, Docetaxol, Anhydrous Docetaxel
Disclaimer
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
